COVID-19 N-Protein PharmaGenie ELISA Kit (SBRS1710)

The SARS-CoV-2 nucleocapsid protein (N-protein) is one of the most abundantly expressed viral antigens during infection, making it a prime target for immunoassay-based detection in COVID-19 research. This Assay Genie ELISA kit is configured as a 96-assay format and is validated for quantitative measurement of N-protein in cell culture supernatants, nasopharyngeal swab specimens, and either plasma or serum samples. Researchers use this assay in seroprevalence studies, vaccine immunogenicity work, and characterization of antiviral compounds, where viral antigen load in infected cell monolayers or patient-derived samples needs to be tracked over time.

The colorimetric readout produces a measurable signal proportional to bound N-protein, and the workflow uses a standard capture-antibody configuration requiring only a standard microplate reader. Reagents should be kept refrigerated and protected from light until use. Because the assay targets the conserved nucleocapsid region, it reacts with SARS-CoV-2 and is intended for research use only.